Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. - Wikidata - awgldk - TriplyDB

Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

http://www.wikidata.org/entity/Q43849799

about

Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study The Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic Review Cationic antimicrobial peptide LL-37 is effective against both extra- and intracellular Staphylococcus aureus Comparison of Outcomes among Adult Patients with Nosocomial Bacteremia Caused by Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus: A Retrospective Cohort Study Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.Epidemiology and outcomes of community-onset methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore.Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study Characteristics of invasive Staphylococcus aureus infections in three regions of Korea, 2009-2011: a multi-center cohort study A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation.Staphylococcus aureus antimicrobial susceptibility of abscess samples from adults and children from the Kaleida Health System in western New York State, 2003 to 2006.Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia.Should central venous catheter be systematically removed in patients with suspected catheter related infection?Metabolic profiling for detection of Staphylococcus aureus infection and antibiotic resistance.Risk factors for mortality among patients with Staphylococcus aureus bacteremia: a single-centre retrospective cohort study Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.Predictive factors for metastatic infection in patients with bacteremia caused by methicillin-sensitive Staphylococcus aureus.Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia Risk and prognosis of Staphylococcus aureus bacteremia among individuals with and without end-stage renal disease: a Danish, population-based cohort study.Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study.Review of Staphylococcus aureus infections requiring admission to a paediatric intensive care unit.Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study agr dysfunction affects staphylococcal cassette chromosome mec type-dependent clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse.Predictors of mortality in Staphylococcus aureus Bacteremia Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.Predictive Value of C-Reactive Protein (CRP) in Identifying Fatal Outcome and Deep Infections in Staphylococcus aureus Bacteremia Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.The value of infectious diseases consultation in Staphylococcus aureus bacteremia Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia Improved understanding of factors driving methicillin-resistant Staphylococcus aureus epidemic waves Impact of reduced vancomycin MIC on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia.Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.Plectasin shows intracellular activity against Staphylococcus aureus in human THP-1 monocytes and in a mouse peritonitis model.

P2860

Q24684202-B17AC092-C238-4D2C-A628-2D4CF8CB6BB3 Q26751492-AD3F168B-A59F-435C-8C85-49E90B26BAC9 Q28395363-067742F5-3689-4AE7-B602-2B0116955E01 Q28551659-80A712C0-92ED-4660-9F19-77F388E18AC0 Q30667465-BA4FC395-C4F2-4177-8A13-4278978104F2 Q33318589-526A6EAE-59AC-4930-80CC-B0ABE9A9AE1C Q33378604-5E1F81D4-EEAE-4748-A602-77E521650D4D Q33490115-4EBDB2EE-6485-438A-A02D-8723CC8B4A19 Q33643822-B9F90973-FB62-43F5-ABA3-E7C7A6A0AFEC Q33644439-132AEAFB-2D88-4D39-BA66-3ED29463AD84 Q33723124-335174BF-B6F8-4813-B26E-BFA36FDBAE71 Q33778191-8AE07CAB-BACE-4CF1-BFAE-848B7559868E Q33827121-CAA409B9-5305-43BA-9FDE-2D619A530FB1 Q33876454-BCBC0315-C05D-4F03-8E5A-F98B50D7A328 Q34447860-F2A24502-42D7-4AD7-BF03-A864B02BFA34 Q34579089-D49B6857-A8B8-402C-8809-329FA3125627 Q34602823-901A1645-7205-464C-BC3C-4CACFB688923 Q34730284-F2A23737-5ABC-4E53-ADBB-28712FFC9C46 Q34737534-590861F2-3CCA-4003-B07D-8D4C2B3B8753 Q34796934-7C9E9C4A-973B-4D74-974A-CDB720DA0842 Q34973729-0E6BD033-195A-4E11-8324-1530A5C9DC15 Q34976131-3C196366-D140-4BA5-AEF7-DDF5F33DA3F4 Q35052124-2F24B97A-7CB0-4DBC-A863-B34E95F223DA Q35144554-CE36B532-AC49-4BD2-9EB6-599FEA908EA9 Q35153754-12B7B93A-5530-4FCB-AD83-CEA623D85A84 Q35281882-5B588688-1378-41CA-B5AF-A1247E4107E6 Q35391386-7E157B91-D887-4A6A-A29B-6B42E3F9B133 Q35607900-86B0C835-033C-4E9B-93AA-979AE6A1E74F Q35628948-B3A2ED1A-0995-4263-8DF0-9D963E58C262 Q35940556-024A7961-2DF0-403B-8606-DE265C3BD6A4 Q36008997-C8DF212B-C430-467B-8E1F-7056F3C31B0D Q36018479-11464AE6-29D4-4497-A65B-22FEF8275390 Q36349620-4ED85187-46A7-431F-867C-26FD899892F1 Q36409465-ABE7CDA9-ABAD-43DF-B87F-816D2648ADDE Q36710238-5F10A8F7-A5FC-4FDE-9264-B6A3FC83892A Q36729953-65B3C888-530D-4603-A26C-663227DB00B1 Q36999966-1EE04D7C-09FD-430C-8E5A-4AAE435BFF33 Q37263399-260B3C14-6B42-4074-8D23-D869DAC900F2 Q37356506-A7FD0BF2-4044-4016-A194-F6D00791A1EC Q37409954-DBDFDE11-AA56-41DA-95C0-5AB877DEDA0C

P2860

Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.

http://www.wikidata.org/entity/Q43849799

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Treatment and outcome of Staph ...... rospective study of 278 cases.

@en

Treatment and outcome of Staph ...... rospective study of 278 cases.

@nl

type

label

Treatment and outcome of Staph ...... rospective study of 278 cases.

@en

Treatment and outcome of Staph ...... rospective study of 278 cases.

@nl

prefLabel

Treatment and outcome of Staph ...... rospective study of 278 cases.

@en

Treatment and outcome of Staph ...... rospective study of 278 cases.

@nl

P1433

Q43849799-F43355E7-449C-462A-B604-C0D2C395C8C4

P1476

Q43849799-E48E892F-4FDD-40F3-8ADC-81ECF21ABA00

P2093

Q43849799-17B9D875-BE29-431C-98A4-C445CF10C71F

Q43849799-84426146-5AA8-4746-BC95-433D56CC104C

Q43849799-894DD24D-8A94-40D8-8511-BA4D29166013

Q43849799-B370D6F0-95E1-448F-AEC6-FF6290F269D4

Q43849799-C272C3EB-E464-41BE-80CB-D164382D0B05

Q43849799-E4279877-9086-4A69-9340-6DCD6E85F8E8

P304

Q43849799-1F282274-A7D9-40F8-B15E-CE02A0219A4E

P31

Q43849799-3473510E-71F9-49A8-BDF3-36759F6069C0

P356

Q43849799-DA6D88B5-CB14-4CB8-AA9E-1F44530A8EA9

P407

Q43849799-C5E25F01-B8D6-4B38-BDA1-ABF8E0823992

P433

Q43849799-8F563D1B-14E7-42A5-9DAF-42AA6BCEA1A1

P478

Q43849799-248DCC12-B96D-4266-A799-0689E0F2D7A0

P577

Q43849799-9122C5A3-9F81-4A77-8E30-66EB6EC448A7

P698

Q43849799-1D0EF3CF-CCE9-4383-837D-29DC62B2736D

P356

ARCHINTE.162.1.25

P1433

JAMA Internal Medicine

P1476

Treatment and outcome of Staph ...... rospective study of 278 cases.

@en

P2093

Allan G Jensen

http://www.w3.org/2001/XMLSchema#string

Carsten H Wachmann

http://www.w3.org/2001/XMLSchema#string

Frank Espersen

http://www.w3.org/2001/XMLSchema#string

Jens Scheibel

http://www.w3.org/2001/XMLSchema#string

Niels Frimodt-Møller

http://www.w3.org/2001/XMLSchema#string

Peter Skinhøj

http://www.w3.org/2001/XMLSchema#string

P304

25-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTE.162.1.25

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11784216

http://www.w3.org/2001/XMLSchema#string